Literature DB >> 30730544

Two-Year Incidence of Retinal Intervention in Patients With Minimal or No Diabetic Retinopathy on Telemedicine Screening.

Bobeck S Modjtahedi1,2,3, Christos Theophanous2, Stephan Chiu2, Tiffany Q Luong3, Natasha Nguyen2, Donald S Fong1,2,3.   

Abstract

Importance: Most patients with diabetes have little or no retinopathy on initial examination. Tracking the long-term outcomes of these patients may increase our understanding of how to best provide follow-up treatment. Objective: To assess how many patients with minimal or no retinopathy require retinal intervention within 2 years of retinal evaluation. Design, Setting, and Participants: This retrospective cohort study assessed patients who underwent screening for diabetic retinopathy within a telemedicine program at Kaiser Permanente Southern California and had minimal or no retinopathy on fundus photographs. Exposure: Retinal interventions performed within 2 years of photographs. Main Outcomes and Measures: Patients with minimal or no retinopathy on initial screening photographs taken in 2012 had their medical records searched for Current Procedural Terminology codes for intravitreal injections, retinal lasers, or pars plana vitrectomy. The medical records of patients identified as having received these interventions within 2 years of retinal evaluation were then manually reviewed for further characterization.
Results: Diabetic retinopathy screening photographs were taken for 116 134 patients (mean [SD] age, 58 [12.8] years; 54 582 [47.0%] female; 46 453 [40.0%] Latino). Of these patients, 79 445, including 69 634 patients without retinopathy and 9811 patients with minimal retinopathy, had 2 years of follow-up. Eleven patients without baseline retinopathy required treatment of diabetic retinopathy in the following 2 years (1 of 12 660 or 0.000079 patients per year), and 11 patients with minimal retinopathy required intervention during the same period (1 of 1784 or 0.000561 patients per year). In addition, retinal interventions were performed for conditions not directly related to diabetic eye disease in 44 patients without baseline retinopathy (1 of 3165 or 0.000316 patients per year) and 5 patients with minimal retinopathy at baseline (1 of 3924 or 0.000255 patients per year). Conclusions and Relevance: These findings suggest that it is rare for patients with minimal or no baseline retinopathy to require retinal interventions in the 2 years after retinal evaluation. It appears that extending the recommended follow-up interval for low-risk patients may be reasonable as long as this does not lead to worse follow-up in later years, because most are unlikely to have vision-threatening disease that necessitates treatment.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30730544      PMCID: PMC6459096          DOI: 10.1001/jamaophthalmol.2018.6912

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  8 in total

1.  Telemedicine and eye examinations for diabetic retinopathy: a time to maximize real-world outcomes.

Authors:  Paolo S Silva; Lloyd Paul Aiello
Journal:  JAMA Ophthalmol       Date:  2015-05       Impact factor: 7.389

Review 2.  Evidence for Telemedicine for Diabetic Retinal Disease.

Authors:  Aditi Gupta; Jerry Cavallerano; Jennifer K Sun; Paolo S Silva
Journal:  Semin Ophthalmol       Date:  2016-10-17       Impact factor: 1.975

3.  Long-term Comparative Effectiveness of Telemedicine in Providing Diabetic Retinopathy Screening Examinations: A Randomized Clinical Trial.

Authors:  Steven L Mansberger; Christina Sheppler; Gordon Barker; Stuart K Gardiner; Shaban Demirel; Kathleen Wooten; Thomas M Becker
Journal:  JAMA Ophthalmol       Date:  2015-05       Impact factor: 7.389

4.  Centralized Reading Center Improves Quality in a Real-World Setting.

Authors:  Sharon M Hudson; Richard Contreras; Michael H Kanter; Stephen J Munz; Donald S Fong
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2015-06       Impact factor: 1.300

5.  Comparison of Nondiabetic Retinal Findings Identified With Nonmydriatic Fundus Photography vs Ultrawide Field Imaging in an Ocular Telehealth Program.

Authors:  Paolo S Silva; Jerry D Cavallerano; Nour Maya N Haddad; Dorothy Tolls; Komal Thakore; Bina Patel; Mina Sehizadeh; Ann M Tolson; Jennifer K Sun; Lloyd Paul Aiello
Journal:  JAMA Ophthalmol       Date:  2016-03       Impact factor: 7.389

6.  Potential efficiency benefits of nonmydriatic ultrawide field retinal imaging in an ocular telehealth diabetic retinopathy program.

Authors:  Paolo S Silva; Jerry D Cavallerano; Dorothy Tolls; Ahmed Omar; Komal Thakore; Bina Patel; Mina Sehizadeh; Ann M Tolson; Jennifer K Sun; Lloyd M Aiello; Lloyd Paul Aiello
Journal:  Diabetes Care       Date:  2013-08-12       Impact factor: 19.112

Review 7.  Extending the diabetic retinopathy screening interval beyond 1 year: systematic review.

Authors:  Sian Taylor-Phillips; Hema Mistry; Rachael Leslie; Dan Todkill; Alexander Tsertsvadze; Martin Connock; Aileen Clarke
Journal:  Br J Ophthalmol       Date:  2015-01-13       Impact factor: 4.638

8.  Comparison of Early Treatment Diabetic Retinopathy Study Standard 7-Field Imaging With Ultrawide-Field Imaging for Determining Severity of Diabetic Retinopathy.

Authors:  Lloyd Paul Aiello; Isoken Odia; Adam R Glassman; Michele Melia; Lee M Jampol; Neil M Bressler; Szilard Kiss; Paolo S Silva; Charles C Wykoff; Jennifer K Sun
Journal:  JAMA Ophthalmol       Date:  2019-01-01       Impact factor: 8.253

  8 in total
  8 in total

1.  Factors Associated with Adherence to Screening Guidelines for Diabetic Retinopathy Among Low-Income Metropolitan Patients.

Authors:  Jessica Kuo; James C Liu; Ella Gibson; P Kumar Rao; Todd P Margolis; Bradley Wilson; Mae O Gordon; Emily Fondahn; Rithwick Rajagopal
Journal:  Mo Med       Date:  2020 May-Jun

Review 2.  Scaling Up Teleophthalmology for Diabetic Eye Screening: Opportunities for Widespread Implementation in the USA.

Authors:  Yao Liu; Alejandra Torres Diaz; Ramsey Benkert
Journal:  Curr Diab Rep       Date:  2019-08-02       Impact factor: 4.810

3.  Awareness of Diabetic Retinopathy: Insight From the National Health and Nutrition Examination Survey.

Authors:  Kristen M J H Nwanyanwu; Marcella Nunez-Smith; Thomas W Gardner; Mayur M Desai
Journal:  Am J Prev Med       Date:  2021-08-21       Impact factor: 5.043

Review 4.  Telemedicine in diabetic retinopathy screening in India.

Authors:  Kim Ramasamy; Chitaranjan Mishra; Naresh B Kannan; P Namperumalsamy; Sagnik Sen
Journal:  Indian J Ophthalmol       Date:  2021-11       Impact factor: 1.848

5.  Sustaining Gains in Diabetic Eye Screening: Outcomes from a Stakeholder-Based Implementation Program for Teleophthalmology in Primary Care.

Authors:  Yao Liu; Julia N Carlson; Alejandra Torres Diaz; Loren J Lock; Nicholas J Zupan; Todd D Molfenter; Jane E Mahoney; Mari Palta; Deanne Boss; Timothy D Bjelland; Maureen A Smith
Journal:  Telemed J E Health       Date:  2020-11-19       Impact factor: 3.536

Review 6.  The Role of Telemedicine, In-Home Testing and Artificial Intelligence to Alleviate an Increasingly Burdened Healthcare System: Diabetic Retinopathy.

Authors:  Janusz Pieczynski; Patrycja Kuklo; Andrzej Grzybowski
Journal:  Ophthalmol Ther       Date:  2021-06-22

Review 7.  The Evolution of Diabetic Retinopathy Screening Programmes: A Chronology of Retinal Photography from 35 mm Slides to Artificial Intelligence.

Authors:  Josef Huemer; Siegfried K Wagner; Dawn A Sim
Journal:  Clin Ophthalmol       Date:  2020-07-20

8.  Vitamin D supplementation in the treatment of type 2 diabetic microangiopathy: A protocol for a systematic review and meta-analysis.

Authors:  Junmin Chen; Xiayu Gong; Jie Liu; Tingting Wang; Xiaoyan Shi; Xiaoran Zhang; Qiu Chen
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.